Agilent Technologies has stepped out of its comfort zone to pursue
a new line of business in ribonucleic acid (RNA) production, with
the recent acquisition of SynPro.
As the threat of new viruses like avian influenza have heightened
the need for greater speed and safety in vaccine production, single
use technologies are proving far more safe and economic than
traditional cleaning techniques, according...
Kurve Technology has announced it has entered into a partnership
with US pharmaceutical firm Schering-Plough involving its nasal
drug delivery device which promises greater efficacy and efficiency
than traditional devices such as...
ESA Biosciences make available its HPLC detection tool that is
designed for laboratories that use THF (tetrahydrofuran) as a
component in chromatographic separations and sample analyses.
A new interactive voice response (IVR) package is available for
small clinical trials, aimed at companies who previously found this
technology unaffordable.
American Peptide Company (APC) has entered into a manufacturing
agreement with Affymax for the clinical supply of the first in its
pipeline of peptide-based drugs.
AppTec Laboratory Services has signed a new contract to manufacture
Chromos Molecular Systems's new multiple sclerosis (MS) drug for
pre-clinical safety and toxicology studies.
A team of researchers have developed a strategy in which genes
linked to cancer mutations could easily be identified aiding
predictions as to which patient will respond favourably to novel
drug treatments.
Despite lingering ethical, legal and social concerns, the
application of stem cell research in drug discovery and development
is set to play a greater role as areas of unmet medical needs will
need to be addressed as rates of incidence...
The possibility of a new class of anti-inflammatory compounds that
exhibit broad action across multiple therapeutic sites could be on
the horizon after Reata announced the completion of a license
agreement for these drug candidates...
Contract manufacturing services provider Dowpharma, has signed a
collaboration agreement for its Pfenex Expression Technology, its
fourth agreement in 1Q 2006, signifying the technology's popularity
in developing new vaccines...
US packaging specialist, Comar, chose Interphex, New York, to
launch its new custom design and production service for
pharmaceutical packaging, offering customers a free initial
consultation.
Olympus launches its latest screening station for the life science
industry, in which the design aims to combine the modularity and
flexibility of a microscope-based set-up with the automation and
throughput of screening applications.
Scientists have made a remarkable discovery that could open up new
avenues in drug development resulting in novel therapies for the
treatment of poxviruses such as variola virus, the cause of
smallpox.
Outsourcing outfit, Oxford Genome Sciences and the University of
Oxford have announced the development of new clinical biomarkers
for colorectal cancer, which paves the way for a more personalised
approach in treating this killer...
After three acquisitions in two months, inVentiv Health has now
expanded capacity in two of its divisions to meet the needs of its
jump in client base.
Ablynx and Procter and Gamble have announced the extension of its
Nanobody drug discovery and development agreement to metabolic
targets in a move that reinforces the feeling within the industry
regarding Nanobody technology and its...
Sigma-Aldrich launches an online tool consisting of data detailing
biological pathways that provides an online resource to those in
the drug industry interested in first-in-class range, including
small molecules, antibodies, enzymes,...
Momenta, a US biotech company whose polysaccharide technology for
the delivery and improved formulation of existing drugs promises
lucrative revenues, is worried its generic version of
Sanofi-Aventis's Lovenox may be in jeopardy...
Nanoparticle product provider Microfluidics has used this year's
Interphex show to introduce products based on its Microfluidizer
processor technology, providing solutions for laboratory and
manufacturing applications that use...
BioTools Swiss has made available its new media preperator for the
laboratory automation industry, which claims to be the fastest
processor of readily dispensable agar/nutrient medium.
American chemists have found that seeds of the sweetgum fruit
contain significant amounts of shikimic acid, the main starting
material for Tamiflu, in a discovery that could prove vital, as
demand for the drug skyrockets amidst bird...
Olympus has unveiled a working concept of what is claimed is the
next generation in fluorescence in vivo imaging systems by enabling
time-lapse and live imaging of emitted light from labelled
processes and tissues.
The growth spurt continues for Icon Clinical Research as it opens
up a new office in Milan, Italy, following a recent acquisition and
two new global contracts.
Watson Pharmaceuticals is selling its unprofitable injectables
manufacturing plant and pulling out of this market segment
altogether. The Company is now establishing contract manufacturing
agreements to take over the 15 products affected.
Beckman Coulter launches its latest monoclonal antibody that
identifies Tolereogenic cells making it highly in transplant and
cancer research. It is also applicable in clinical research on
autoimmunity.
VASTox has initiated a fifth drug discovery programme for cancer
focusing on a crucial pathway that is active in the developing
embryo when cells are required to constantly grow and
differentiate. The pathway has been identified as...
Melbourn Scientific, report an eventful month in which the
expansion of its range of services has resulted in the purchase of
new premises, as well as meeting requirements of good manufacturing
practice that regulate the manufacture...
Shire, Britain's third-biggest drugmaker, has won approval in the
US for Daytrana, a methylphenidate skin patch developed with
Noven's transdermal technology, making it the first non-oral
medication for the treatment of...
Impinj showcased what it claims is the world's first application of
ultra-high frequency (UHF) Gen 2 RFID technology for item-level
tagging of pharma products.
Screening and processing equipment supplier Kason, were out in
force at InterPhex 2006, with a range of products that aid the
manufacturing industry meet stringent pharmaceutical sanitary
requirements.
Thanks to a £2.7m (€3.9m) access fund from the UK's National
Biomanufacturing Centre (NBC), biotech firm Onyvax has hired
contract manufacturer organisation (CMO) Eden Biodesign to supply
it with clinical current good manufacturing...
Texas Instruments used the recent Interphex show in New York to
demonstrate its unique approach to improving the security of
budding radio frequency identification (RFID) technology.
US drug maker Bristol-Myers Squibb has said it will invest $200m
(€166m) to expand its Puerto Rico facility, driven by a thirst for
biologics that the firm is trying to quench, both in-house and
through contract manufacturing.
Olympus is gearing up to launch the two latest models in its range
of stereo microscopes, hailed as offering scientists superior
sensitivity with the highest zoom ratio and resolution on the
market.
ThermoSafe Brands has unveiled a pre-qualified, reusable shipping
system, which enables the safe transportation of bulk quantities of
pharmaceutical and vaccine substances under optimal temperatures.
Israel's TransPharma has announced the results of the first
clinical trials of human Parathyroid Hormone 1-34 fragment (hPTH
1-34), delivered with its hand-held pen-size transdermal device,
showed its system can systemically...
To increase the chance of success in IT outsourcing, companies must
increase their focus on creating and managing a successful mixture
of supplier relationships that work for them.
Wyatt Technology launches its newest addition to its Multi-Angle
Light Scattering (MALS) Detector range, boasting twice the signal
to noise ratio and 100x the dynamic range of previous Wyatt's
miniDAWN instruments.
For the first time in its 30-year history, the biotechnology
industry in 2005 surpassed $60bn (€49bn) in revenues according to
Ernst & Young's 2006 Global Biotechnology Report, an astounding
growth considering that in 1996...
Tapestry has presented data that supports the oral bioavailability
and antitumour activity of its drug candidate designed to overcome
multi-drug resistance in solid tumours that have become resistant
to taxane therapy.
Eden Biodesign and Onyvax have announced the formation of a unique
biomanufacturing contract, in which the Onyvax's development of
novel cancer therapies will be supported by Eden's cGMP clinical
manufacturing services.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA)
has said it has so far found no evidence of wrongdoing in the human
trials of the monoclonal antibody TGN1412, which US contract
research firm Parexel carried...
The Russian pharmaceutical market is giving its rivals a run for
their money, jumping 35 per cent in 2005 to $9bn (€7.3bn) -
compared to 28 per cent growth in China and 37 per cent growth in
Brazil - as foreign pharmaceutical manufacturers...
Chemical firm BASF has announced it has developed a new formulation
for its Ibuprofen DC 85, an active substance in anti-inflammatory
and analgesic products, using a nanocoating which, thanks to its
resistance to high temperature,...
